72036722RFA00003: USAID Education: Equity and Inclusion (This is USAID/Nepal NOFO)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Thailand USAID-Bangkok notices from 2022.
Thailand USAID-Bangkok offered grants of up to $20.0 million to any type of organization. It expected to make one award worth $20.0 million in total. Applications closed on September 14, 2022.
From the official notice on Grants.gov, last changed August 24, 2022. Checked November 7, 2026.
- Award ceiling$20.0 million
- Total funding$20.0 million
- Expected awards1
- Cost sharingRequired
- Funding typeCooperative Agreement
Key dates
| Posted | July 18, 2022 |
|---|---|
| Deadline | September 14, 2022 |
| Archived by Grants.gov | September 15, 2022 |
Who can apply
This opportunity was open to any type of organization.
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Is this a realistic fit?
- Past USAID Foreign Assistance for Programs Overseas awards averaged $8.7 million; this notice allows up to $20.0 million per award.
- Most of the program's money (54% over five years) went to nonprofits.
- The notice requires cost sharing or matching funds, so you must contribute part of the project cost.
What the grant funds
RFA Issuance Date: July 18, 2022 Deadline for Questions: July 27, 2022, RFA Amendment Date: August 24, 2022 Deadline for Applications: September 14, 2022, 9:00 a.m., Eastern Time Subject: Notice of Funding Opportunity (NOFO) Request for Application (RFA) No. 72036722RFA00003 RFA Amendment No. 2 Activity Title: USAID Education: Equity and Inclusion Dear Potential Applicants: The purpose of this amendment to the NOFO is to incorporate changes in Section D.7 UNIQUE ENTITY IDENTIFIER AND SAM REQUIREMENTS as highlighted on the next page. All other terms and conditions indicated in the above-mentioned solicitation issued on July 18, 2022 and its Amendment No. 1 issued on August 8, 2022 remain unchanged. Thank you for your interest in USAID programs. Sincerely, -s- Robyn Bertholon Agreement Officer USAID/Nepal/OAA -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- RFA Issuance Date: July 18, 2022 Deadline for Questions: July 27, 2022, RFA Amendment Date: August 8, 2022 Deadline for Applications: September 14, 2022, 9:00 a.m, Eastern Time Subject: Notice of Funding Opportunity (NOFO) Request for Application (RFA) No. 72036722RFA00003 RFA Amendment No. 1 Activity Title: USAID Education: Equity and Inclusion Dear Potential Applicants: The purpose of this amendment to NOFO is to incorporate changes as follows: Address questions submitted in written by the due date of July 27, 2022 in response to NOFO No. 72036722RFA00003, and Revise the NOFO as a result thereof. The NOFO with highlighted changes is also attached with this Amendment. All other terms and conditions indicated in the above-mentioned solicitation issued on July 18, 2022 remain unchanged. Thank you for your interest in USAID programs. Sincerely, -s- Maria Televantos Agreement Officer USAID/Nepal/OAA -------------------------------------------------------------------------------------------------------------------------------- Issue Date: July 18, 2022 Deadline for Question: July 27, 2022 at 5.00 p.m. Eastern Time Closing Date for Technical Application: September 14, 2022 at 9.00 a.m.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72036722RFA00003 still open?
No. It closed on September 14, 2022.
Who can apply for USAID Education: Equity and Inclusion (This is USAID/Nepal NOFO)?
Thailand USAID-Bangkok accepted applications from any type of organization.
What is the deadline for USAID Education: Equity and Inclusion (This is USAID/Nepal NOFO)?
Closed September 14, 2022. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $20.0 million each. About $20.0 million in total for one award.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Impact Aid Discretionary Construction Grant Program - 84.041C
- NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)